# Guangzhou Jiajian medical testing Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guangzhou-jiajian-medical-testing-co

- Industry: Healthcare
- Headquarters: Guangzhou, China
- Website: www.amcarelab.com
- Total disclosed funding: $46M
- Latest round: Series B (Jun 9, 2022)
- Investors on record: 12

## About

Based in Guangzhou, China and established in 2015, Guangzhou Jiajian medical testing Co., Ltd. is a medical laboratory focusing on clinical genetics and clinical tumor diagnose. The company has ABMG clinical dual certification. In January 2020, the company raised CNY 110 million in series B funding from Green Pine Capital Partners, Zhuhai Qianfeng Venture Equity Investment Mangement and Ziyuan Invest.

The company provides one-stop solutions close to clinical use with optimized genomic testing products as tools, and provides professional and clinically sound molecular testing instruments, reagents and software for medical institutions at all levels, as well as clinical staff training, end-of-hospital consultations and personalized genetic counseling services. The company has established a complete product system of genetic testing equipment, high-precision gene kits, reagents and custom probes, and has also established a database of tens of thousands of Chinese people's own genetic disease mutations.

The company will focus on the development and registration of the test reagent pipeline. The company will also continue to improve the construction of the upstream and downstream closed-loop system in the genomic disease diagnostic industry and promote the industrial upgrading of genomic diseases.

## Funding rounds

- Series B, Jun 9, 2022, $30M — Guangdong Technology Financial Group, China International Capital Corporation, Jointown Pharmaceutical Group, Bison Capital
- Series B, Jan 19, 2020, $16M — Green Pine Capital Partners, Ziyuan Invest, Zhuhai Qianfeng Venture Equity Investment Mangement
- Series A, Jul 3, 2017 — Zhongda Venture Capital, MED-FINE Capital, Guangdong Medical Valley, Qianshan Capital, Kuimu Capital

## Investors

- Zhongda Venture Capital (https://capitalatlas.ai/funds/zhongda-venture-capital) — Series A
- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series A
- Guangdong Medical Valley — Series A
- Qianshan Capital — Series A
- Kuimu Capital — Series A
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series B
- Ziyuan Invest — Series B
- Zhuhai Qianfeng Venture Equity Investment Mangement — Series B
- Guangdong Technology Financial Group (https://capitalatlas.ai/funds/guangdong-technology-financial-group) — Series B
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series B
- Jointown Pharmaceutical Group — Series B
- Bison Capital — Series B